Professional Summary
Professional Overview
Paul Sekhri is a seasoned healthcare executive with over three decades of experience in the biopharmaceutical industry. Leveraging his deep expertise in drug development, strategic planning, and corporate leadership, he currently serves as the Chairman, President and CEO of vTv Therapeutics, Inc., a clinical-stage pharmaceutical company focused on developing innovative treatments for Alzheimer's disease, type 2 diabetes, and other serious conditions.
Experience Summary
Current Role
As the Chairman, President and CEO of vTv Therapeutics, Paul oversees the company's strategic direction, clinical development programs, and overall operations. Under his leadership, vTv Therapeutics has advanced multiple drug candidates through clinical trials and made significant progress in its efforts to bring novel therapeutics to market.
Prior to his current role, Paul held several high-profile positions, including serving as the Chairperson of the Board of Resolution Therapeutics, a board member at AdhereTech and Veeva Systems, and the Chairman of the Board at Compugen Ltd. His diverse experience and deep industry knowledge have enabled him to drive innovation and strategic growth across various organizations.
Career Progression
Throughout his distinguished career, Paul has held leadership roles at some of the most prominent biopharmaceutical companies. He previously served as the Group Executive Vice President and Head of the Life Sciences Sector at Teva Pharmaceutical Industries, where he was responsible for the company's global specialty and generic pharmaceutical businesses. Prior to that, he held senior executive positions at Novartis AG, including roles as the Head of the Biopharmaceuticals and Oncology Injectables Business Units and the Head of Corporate and Business Development.
Paul's extensive experience and proven track record of success have earned him a reputation as a strategic and visionary leader in the healthcare industry. He has played a pivotal role in the development and commercialization of numerous innovative therapies, and his contributions have had a significant impact on the lives of patients worldwide.
Academic Background
Paul holds a Bachelor of Science degree from the City College of New York, where he graduated with honors. His academic achievements and strong educational foundation have provided a solid foundation for his successful career in the biopharmaceutical industry.
Areas of Expertise
- Drug development and clinical trial management
- Strategic planning and corporate leadership
- Mergers, acquisitions, and business development
- Regulatory affairs and market access
- Biopharmaceutical industry trends and innovation
Professional Impact
Throughout his career, Paul has been recognized for his outstanding contributions to the healthcare industry. He has served on the boards of several public and private companies, leveraging his deep industry knowledge and strategic insights to drive growth and create value for shareholders.
Paul's leadership has been instrumental in the advancement of numerous drug candidates through the clinical pipeline, addressing unmet medical needs and improving patient outcomes. His ability to navigate complex regulatory environments and successfully bring innovative therapies to market has cemented his reputation as a respected and influential figure in the biopharmaceutical industry.
Conclusion
With his extensive experience, strategic vision, and proven track record of success, Paul Sekhri is well-positioned to continue driving innovation and growth at vTv Therapeutics. His commitment to advancing the development of novel treatments and improving patient lives aligns with the company's mission, making him an invaluable asset in the pursuit of delivering breakthrough therapies to the market.
